[Microcirculation of skeletal muscle after ischemia and reperfusion]
- PMID: 8379164
[Microcirculation of skeletal muscle after ischemia and reperfusion]
Abstract
The postischemic reperfusion-damage in the microcirculation of skeletal muscle is characterized by 1) heterogenous capillary perfusion with capillary perfusion deficiency ("no reflow"), 2) microvascular accumulation of leukocytes, which adhere to the endothelium of postcapillary venules, and 3) increase of vessel permeability with swelling of endothelial cells and with interstitial edema. Two models of pathomechanism may be differentiated: The capillary perfusion-deficiency of the no-reflow phenomenon prolongs the duration of ischemia extending the period of postischemic reperfusion and induces the tissue-damage by further decrease of tissue-pH, by loss of energy rich phosphates and by a deficit of oxygen supply to tissue. On the other hand, reperfusion with consecutive reentry of molecular oxygen into the microvasculature provokes the formation of oxygen-radicals and the accumulation of leukocytes adhering to the endothelium of postcapillary venules ("reflow-paradox"). The activated white blood cells release additional oxygen-radicals and deliver aggressive mediators, such as proteases, cytokines and eicosanoids, which have chemotactic influence on leukocytes. This results in a vicious circle in which oxygen-radicals and mediators are responsible for the augmentation of postischemic tissue-damage. Prophylactic isovolemic hemodilution to a hematocrit of 30% with dextran 60 reduces the postischemic capillary perfusion deficiency (no reflow); therapy with "oxygen radical scavengers" and xanthinoxydase-inhibitors reduces accumulation/adherence of leukocytes as well as the damage to the endothelial lining with increased microvascular permeability (reflow-paradox). Intermittent reperfusion/reoxygenation influences both components of postischemic microcirculation damage and is therefore a simple clinical approach for reducing the ischemia/reperfusion-syndrome in elective surgery.
Similar articles
-
Microvascular in vivo assessment of reperfusion injury: significance of prostaglandin E(1) and I(2) in postischemic "no-reflow" and "reflow-paradox".J Surg Res. 2004 Jul;120(1):1-11. doi: 10.1016/S0022-4804(03)00332-9. J Surg Res. 2004. PMID: 15172184
-
Spatial and temporal correlation between leukocyte behavior and cell injury in postischemic rat skeletal muscle microcirculation.Lab Invest. 1994 May;70(5):684-95. Lab Invest. 1994. PMID: 7910874
-
Pentoxifylline reduces venular leukocyte adherence ("reflow paradox") but not microvascular "no reflow" in hepatic ischemia/reperfusion.J Surg Res. 1997 Jul 15;71(1):1-6. doi: 10.1006/jsre.1997.5132. J Surg Res. 1997. PMID: 9271270
-
Role of oxygen radicals in the microcirculatory manifestations of postischemic injury.Klin Wochenschr. 1991 Dec 15;69(21-23):1050-5. doi: 10.1007/BF01645157. Klin Wochenschr. 1991. PMID: 1665884 Review.
-
Capillary dysfunction in striated muscle ischemia/reperfusion: on the mechanisms of capillary "no-reflow".Shock. 1997 Jul;8(1):2-7. Shock. 1997. PMID: 9249906 Review.
Cited by
-
Improvement of postischemic hepatic microcirculation after endothelinA receptor blockade--endothelin antagonism influences platelet-endothelium interactions.J Gastrointest Surg. 2005 Feb;9(2):187-97. doi: 10.1016/j.gassur.2004.06.006. J Gastrointest Surg. 2005. PMID: 15694814
-
Effects of CD11b/18 monoclonal antibody on rats with permanent middle cerebral artery occlusion.Am J Pathol. 1996 Jan;148(1):241-8. Am J Pathol. 1996. PMID: 8546211 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources